The gene encoding BLIP, a beta-lactamase-inhibitory protein, was disrupted in wild-type Streptomyces clavuligerus and in a clavulanic acid non-producing mutant. The resulting BLIP mutant and BLIP/clavulanic acid double mutant showed no residual proteinaceous β-lactamase-inhibitory activity, indicating that only a single β-lactamase-inhibitory protein exists in S. clavuligerus. The lack of any proteinaceous β-lactamase-inhibitory activity in the bli and bli/claR mutants also indicates that BLP, the BLIP-like protein, encoded by S.
INTRODUCTION
Streptomyces spp. are filamentous Gram-positive soil bacteria known for their complex life cycle and their production of a large variety of biologically active secondary metabolites, degradative enzymes and enzyme inhibitors. Streptomyces clavuligerus has been the subject of extensive research in the last 30 years because 
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of its ability to produce β-lactam metabolites with antibiotic, antifungal and β-lactamase-inhibitory activities. The major β-lactam compounds produced by S. clavuligerus are shown in Fig. 1 . Penicillin N and cephamycin C are antibiotics while clavam-2-carboxylate, hydroxymethyl clavam, alanyl clavam and 2-formyloxymethyl clavam have weak antibacterial activity but have also been shown to have antifungal activities (Pruess & Kellett, 1983) . In addition to these, S. clavuligerus is well known as the species used for the industrial production of clavulanic acid. Clavulanic acid differs from the other four clavams in that it has C-5R stereochemistry, which is opposite to the C-5S stereochemistry of the other clavams. Furthermore, it has a carboxyl group at the C-3 position not seen in the other clavams. Although low in antibacterial activity, clavulanic acid has become a clinically important product of S. clavuligerus due to its potent inhibitory activity against a large number of β-lactamases (Baggaley et al., 1997) .
In addition to clavulanic acid S. clavuligerus also produces a second β-lactamase inhibitor, BLIP, which stands for beta-lactamase-inhibitory protein. BLIP is a 17n5 kDa exocellular protein that inhibits TEM β-lactamase in a noncovalent fashion (Doran et al., 1990) . Little is known about the function of BLIP beyond its β-lactamase-inhibitory activity. β-Lactamase-inhibitory proteins have also been detected in the culture supernatants of other Streptomyces spp. A proteinaceous inhibitor from Streptomyces gedanensis showing activity against the Staphylococcus aureus β-lactamase was reported by Hata et al. (1972) but no further characterization of this activity has appeared. Two β-lactamase-inhibitory proteins have been described and partially characterized from Streptomyces exfoliatus (Kim & Lee, 1994) . BLIP-II of S. exfoliatus is larger than the S. clavuligerus BLIP, at 33 kDa. The gene encoding BLIP-II (bliB) has been cloned and sequenced, but the predicted amino acid sequence of BLIP-II does not show any significant similarity to BLIP from S. clavuligerus (Park & Lee, 1998) . In contrast, the gene encoding BLIP-I (bliA) has recently been cloned and sequenced and BLIP-I was shown to be similar in size (17n5 kDa) and sequence (38 % identity) to BLIP from S. clavuligerus (Kang et al., 2000) . Furthermore, bliA has been disrupted and shown to impose a bald phenotype on the mutant strain. Unlike S. clavuligerus, S. exfoliatus is not known to produce any β-lactam metabolites. Perez-Llarena et al. (1997a) have also reported the presence of a gene in S. clavuligerus that encodes a putative protein called BLP, for BLIP-like protein. The amino acid sequence of BLP shows significant similarity to BLIP, with 29n2 % identical and an additional 27n6% functionally conserved residues. Interestingly, the BLPencoding gene, blp, is located within the cephamycin C biosynthetic gene cluster but BLP does not appear to be required for production of β-lactam antibiotics since deletion of the blp gene has no detectable phenotype, including no effect on cephamycin C production (Alexander & Jensen, 1998) . Doran et al. (1990) suggested that BLIP might function as a regulator of cell wall growth or morphogenesis in S. clavuligerus. More recently, Perez-Llarena et al. (1997b) reported the discovery of a β-lactamase-encoding gene (bla) in S. clavuligerus. The β-lactamase, when produced in a heterologous species, had poor catalytic activity, two to four orders of magnitude lower than other class A enzymes against penicillin G. When assayed against clavulanic acid, the S. clavuligerus β-lactamase was found to be sensitive to inhibition by clavulanic acid although the inhibition was weak compared to other target enzymes. Due to its ability to bind penicillin but its weak hydrolysing activity, the authors proposed that this enzyme actually functions in cell wall morphogenesis like a penicillin-binding protein. This theory was also supported by the finding that an analogous β-lactamase in Nocardia lactamdurans is involved in cell wall biosynthesis.
BLIP was also found to have an inhibitory effect on the S. clavuligerus β-lactamase (Perez-Llarena et al., 1997b) and the authors further suggested that the activity of the S. clavuligerus β-lactamase in cell wall synthesis and morphology may be regulated by BLIP and\or clavulanic acid. In this study, a BLIP non-producer mutant was constructed to assess the effects of the absence of BLIP on the development of S. clavuligerus. Furthermore, a BLIP and clavulanic acid double non-producer mutant was constructed to assess the effects of the absence of both of these β-lactamase inhibitors on the growth of the organism.
METHODS
Bacterial strains, plasmids and culture conditions. The bacterial strains and plasmids used in this study are listed in Table Table 1 Sambrook et al. (1989) . For sporulation, S. clavuligerus was grown on ISP-3 medium (Difco) while Streptomyces lividans was grown to produce spore stocks on R2YE without sucrose as described in Hopwood et al. (1985) . Genomic and plasmid DNA was isolated from cultures of Streptomyces spp. grown in trypticase soy broth (TSB) supplemented with 1 % starch (TSBS) with shaking at 280 r.p.m. for 2-3 d until maximum growth was obtained. S. clavuligerus cultures were incubated at 28 mC while S. lividans cultures were grown at 30 mC in flasks equipped with steel springs. Plasmid-bearing cultures were supplemented with 50 µg hygromycin ml − " or 50 µg thiostrepton ml − " for S. lividans, and 5 µg thiostrepton ml − " or 250 µg hygromycin ml − " for S. clavuligerus, as appropriate to the plasmid.
S. lividans was cultivated for the production of protoplasts as described in Hopwood et al. (1985) , while S. clavuligerus was cultivated for the production of protoplasts according to a modification of the method of Bailey & Winstanley (1986) . TSBj1 % maltose (TSBM) medium was inoculated with S. clavuligerus spores and incubated for 3 d at 25 mC and 250 r.p.m. in a flask containing a steel spring. This seed culture was used to inoculate (4 %, v\v) a 25 ml amount of TSBM\ YEMEM combination medium [10 ml TSB, 15 ml YEME (yeast extract\malt extract ; Hopwood et al., 1985) , 1 % maltose and 0n005 M MgCl # ] and the culture was incubated with shaking at 25 mC for 18 h. Mycelium was harvested by centrifugation, washed twice with 10n3 % sucrose and used immediately for the preparation of protoplasts or stored at k70 mC. Streptomyces spp. transformants bearing plasmids with a thiostrepton-resistance marker were selected by overlaying plate cultures with soft nutrient agar (Difco) containing thiostrepton to give a final concentration of 37n5 µg ml − " for S. lividans and 5 µg ml − " for S. clavuligerus. Replica plating of S. clavuligerus was carried out on MYM agar medium (Stuttard, 1982) containing 10 µg thiostrepton ml − " or 250 µg hygromycin ml − ".
S. clavuligerus was cultivated for the assessment of clavam metabolite production by using 48 h TSBS seed cultures to inoculate (2 %, v\v) a complex Soy fermentation medium (Paradkar & Jensen, 1995) . BLIP production and β-lactam antibiotic production by S. clavuligerus were assayed in TSBS broth grown cultures inoculated from a spore suspension and incubated as described above. Penicillin G resistance studies in liquid medium were conducted using S. clavuligerus grown in TSBS broth. For resistance studies on solid medium, S. clavuligerus spores were grown on TSBS agar.
Disruption of the bli gene. pBLIP2 was linearized by digestion with ApaI, and an ApaI\BamHI linker oligonucleotide (5h-GTGGATCCACGGCC-3h) was introduced. The ApaI site is located near the middle of the bli gene. A thiostreptonresistance gene (tsr), released from pIJ702 as a BclI fragment, was introduced into the BamHI site of the bli gene. The bli ::tsr disrupted gene was removed as an EcoRI\PstI fragment, passaged through pIJ2925 to introduce compatible restriction endonuclease sites and then inserted into the BglII site of pJOE829 to generate pJOEbli ::tsr. pJOEbli : :tsr was transformed into S. lividans and from there into wild-type S. clavuligerus and a claR mutant strain of S. clavuligerus. Thiostrepton resistant (Thio R ), hygromycin-resistant (Hyg R ) transformants were transferred to ISP-3 medium plates and allowed to sporulate in the absence of antibiotic selection. The resulting spores were plated on ISP-3 medium to give isolated colonies, and then replica plated onto MYM medium to identify thiostrepton resistant, hygromycin sensitive (Thio R Hyg S ) mutants.
DNA isolation, transformation and Southern blot analysis.
Plasmid DNA was isolated from E. coli, and restriction enzyme digestion and ligation reactions were performed as described in Sambrook et al. (1989) . Generation and transformation of E. coli competent cells was performed as described by Chung et al. (1989) . Streptomyces plasmids were isolated and purified by the alkaline lysis method of Kieser, and Streptomyces genomic DNA was purified according the method of Fisher, both as described in Hopwood et al. (1985) . S. lividans protoplast formation, transformation and regeneration were as described in Hopwood et al. (1985) . S. clavuligerus protoplast formation, transformation and regeneration were as described by Bailey & Winstanley (1986) . Southern blot analysis was performed as described in Sambrook et al. (1989) . DNA probes were labelled with [α$#P]dCTP by nick translation according to the method in Hopwood et al. (1985) . Hybridization reactions were carried out at 65 mC for 16 h in 5iSSPE, 0n5% (w\v) SDS, 5i Denhardt's solution (Sambrook et al., 1989) . Following hybridization, nylon blots were washed twice with 2iSSPEj0n1 % SDS for 10 min at room temperature, once with 1iSSPEj0n1 % SDS at 65 mC for 15 min and finally once with 0n1iSSPEj0n1 % SDS at 65 mC for 15 min.
Quantitation of growth. Growth of Streptomyces cultures was estimated by two methods. For TSBS-grown cultures, optical densities were measured at 600 nm. For cultures grown in Soy fermentation medium, growth was assessed by quantitation of DNA content by the method of Burton as described in Daniels et al. (1994) , using salmon sperm DNA as a standard.
Detection of BLIP by β-lactamase inhibition assay. Culture supernatants were diluted 1 : 1 (v\v) with methanol or water, incubated at 4 mC for 30 min and centrifuged for 5 min at 13 000 r.p.m. in a MicroCentaur bench-top centrifuge. Bactopenase (Difco, 2i10% units in 0n3 ml 0n1 M sodium phosphate buffer pH 7n0), was preincubated at 21 mC for 5 min with 0n2 ml of the diluted culture supernatant. Penicillin G (500 µl of 0n3 mg ml − " solution) was then added and the rate of decrease in absorbance at 240 nm was monitored. The difference between the rate of penicillin G degradation obtained when a culture supernatant sample was diluted with H # O (inhibition due to both clavulanic acid and BLIP) and that obtained when it was diluted with methanol (inhibition due to clavulanic acid only) represents the amount of β-lactamase-inhibitory activity due to BLIP. BLIP activity is expressed as percentage inhibition of Bactopenase assayed under the standard conditions described above. The presence of methanol in the assays at the concentration described above has no effect on β-lactamase activity.
Detection of BLIP by Western analysis. Protein samples were separated on a 10 % SDS-PAG and then transferred to a PVDF membrane (Immobilon-P, Millipore). Transfer was carried out at 1n5 A for 2 h at 4 mC in 25 mM Tris\192 mM glycine at pH 8n3. Following transfer, the blot was blocked with 5 % (w\v) skim milk (Difco) and Western hybridization was carried out using the Chemiluminescence Western Blotting Kit (Roche Diagnostics) according to the manufacturer's instructions. The membrane was probed with primary anti-BLIP antibodies prepared by D. Alexander as described by Alexander & Jensen (1998) . Anti-BLIP antibodies were used at a dilution of 1 : 4000 while the sheep anti-rabbit secondary IgG coupled to horseradish peroxidase (Roche Diagnostics) was used at 1 : 5000.
HPLC assay of clavams and clavulanic acid. HPLC analysis was performed as described by Paradkar et al. (1998) . Clavam-2-carboxylate and clavulanic acid were identified by comparison to authentic standards kindly provided by SmithKline Beecham, Worthing, UK. Hydroxymethyl clavam was identified according to its relative chromatographic mobility in comparison to clavam-2-carboxylate and clavulanic acid (Mosher et al., 1999) .
Bioassay for β-lactam antibiotics. Total β-lactam antibiotics were determined by a bioassay procedure using E. coli ESS as the indicator organism, as described by Aharonowitz & Demain (1978) .
Penicillin G resistance studies. Penicillin G resistance on solid medium was examined using TSBS base agar plates. Each 100i15 mm plate containing 10 ml TSBS agar was overlaid with 5 ml soft TSBS agar containing 1i10( viable spores of S. clavuligerus. Paper bioassay disks of 0n5 in (" 13 mm) diameter (Schleicher and Schuell) containing 50, 100 or 200 µg penicillin G were placed on the inoculated plates at 16 h postoverlay to examine the effect of penicillin G on germinated spores or 10 min post-overlay to examine the effect on ungerminated spores. The plates were then incubated at 28 mC and zones of inhibition were measured at 27 and 38 h. Penicillin G resistance on liquid medium was examined by adding penicillin G to 12 h TSBS cultures to a final concentration of 0, 20 or 60 µg ml − ". At 24 h intervals, samples were removed, homogenized with a disposable pellet pestle mixer (Kontes) and growth was determined as OD '!! . Samples of each culture were also fixed with a drop of polyvinyl alcohol mounting medium on a microscope slide and examined by phase-contrast microscopy.
DNA sequence analysis. The DNA sequences of the regions upstream and downstream of the bli gene were determined using the plasmid pBIP as template and a series of custom oligonucleotide sequencing primers. Dideoxy chain-termination sequencing was performed using a Taq dye-deoxy terminator kit and model 373A sequencer (Applied Biosystems) by the University of Alberta Department of Biological Sciences DNA synthesis lab. Both strands of the template were sequenced in full for the regions reported.
Sequences were compiled using DNA Star software (DNASTAR, Inc.). ORFs were identified using the Codon Preference feature of GCG (Genetics Computer Group, Inc.) with a Streptomyces codon frequency table (Wright & Bibb, 1992) . The sequence information obtained was analysed using the GCG\net program to search for similar protein sequences in the public databases.
RESULTS

Disruption of the bli gene in wild-type S. clavuligerus and in a clavulanic acid non-producer mutant
A BLIP non-producer mutant and a clavulanic acid\ BLIP non-producer double mutant were constructed by gene replacement at the bli locus in wild-type S. clavuligerus and in the clavulanic acid production defective mutant, claR (Paradkar et al., 1998) , respectively. To construct the bli single mutant, pJOEbli ::tsr was introduced into wild-type S. clavuligerus. The bli\claR double mutant was constructed by introducing the same pJOEbli ::tsr disruption construct into an existing claR mutant. The claR mutant is defective in clavulanic acid production and was generated by disruption of claR using an apramycin-resistance gene. claR encodes a transcriptional regulator required for the expression of genes involved in the late steps of clavulanic acid biosynthesis (Paradkar et al., 1998) . Following sporulation of transformants on non-selective medium, and isolation of Thio R Hyg S colonies, seven putative bli single mutants and one bli claR double mutant were obtained.
Confirmation of the gene replacement event by Southern hybridization
Southern hybridization was carried out to confirm that the gene disruption events had taken place at the bli locus of the putative BLIP mutants. Genomic DNA of the wild-type, and the single and double mutants, was digested with KpnI, separated by agarose gel electrophoresis and then blotted onto nylon membranes. The membranes were probed with an 840 bp DNA fragment containing the bli gene and with a 1n09 kb fragment containing the tsr gene. A 5n5 kb bli-hybridizing fragment in wild-type genomic DNA was replaced with a 6n5 kb bli-hybridizing fragment in both the single bli mutant and the bli\claR double mutant, indicating that the KpnI fragment carrying the bli gene had taken up a 1 kb insert, presumably the tsr gene (data not shown). Probing with a labelled tsr gene gave no hybridizing signal in wild-type genomic DNA while a band of 6n5 kb was seen in the DNA digests of the bli mutant and the bli\claR double mutant. This confirmed that the expected gene replacement event had taken place in the bli and bli\claR mutants.
Comparison of β-lactamase-inhibitory protein activity in wild-type S. clavuligerus, the bli mutants, and the bli/claR double mutant To determine if the mutants were defective in the production of BLIP, culture supernatants from the seven bli mutants and the bli\claR double mutant grown in TSBS were assayed for BLIP activity using the β- lactamase inhibition assay. Fig. 2 shows BLIP activity produced by the wild-type, one representative bli mutant and the bli\claR double mutant. Although high levels of BLIP activity were seen in wild-type culture supernatants, BLIP activity was not detected at any time point in either the single or double mutants. The absence of β-lactamase-inhibitory activity in culture supernatants of the bli mutant not only confirms that the expected mutation has taken place, but also shows that only one proteinaceous β-lactamase-inhibitory protein exists in S. clavuligerus.
Effects of bli disruption on morphology, sensitivity to penicillin G and cephamycin C production in S. clavuligerus
Mycelia from TSBS-grown cultures of wild-type S. clavuligerus and the bli and bli\claR mutants were examined by phase-contrast microscopy. No morphological differences were seen between the mutants and the wild-type organism. Sporulation on solid medium was also unaffected by the bli disruption. Resistance to penicillin G was also examined and no difference in penicillin G sensitivity was observed for liquid-or solidmedium-grown cultures of the different mutants and wild-type S. clavuligerus. Cephamycin production by wild-type S. clavuligerus, the bli mutant and the bli\claR double mutant was compared by bioassay against the indicator organism E. coli ESS. Again, no differences in the levels of antibiotic production in TSBS-grown cultures were found between the mutants and wild-type S. clavuligerus (data not shown). 
S. clavuligerus.
To determine if the bli disruption had any effect on clavulanic acid, clavam-2-carboxylate and hydroxymethyl clavam production, culture supernatants from triplicate Soy fermentation medium grown cultures of a representative bli mutant, the claR mutant, the bli\claR double mutant and wild-type S. clavuligerus were analysed by HPLC.
Clavam-2-carboxylate and clavulanic acid peaks were identified by comparison with authentic standards while hydroxymethyl clavam was identified by its known chromatographic properties relative to those of clavam-2-carboxylate and clavulanic acid (Mosher et al., 1999) . The levels of clavam-2-carboxylate produced by wildtype S. clavuligerus, and by the bli, claR, and bli\claR mutants, are shown in Fig. 3 . No differences in the levels of clavam-2-carboxylate produced by the bli mutant and wild-type S. clavuligerus were evident at 48 h although production levels were quite variable in the replicate cultures of the bli mutant (Fig. 3a) . At 72 h, the bli mutant produced levels of clavam-2-carboxylate that were two to five times higher than those seen in the wildtype samples (Fig. 3b) . This difference was transient and was no longer evident in the 96 h samples (Fig. 3c) . At 48 h, the bli\claR double mutant appeared to produce lower amounts of clavam-2-carboxylate than either the claR single mutant or wild-type cultures (Fig. 3a) . Despite this initial lag, by 72 h the bli\claR double mutant showed levels of clavam that were higher than either the wild-type or the claR mutant (Fig. 3b) . By 96 h (Fig. 3c) , the bli\claR and claR mutants were comparable, as was true for the bli and wild-type cultures. Therefore a transient elevated level of clavam-2-carboxylate was detected in the mid-production stages of strains bearing the bli disruption.
A similar pattern of production of hydroxymethyl clavam was seen in the wild-type and mutant cultures. At 72 h bli mutant cultures produced two-to almost tenfold higher levels of hydroxymethyl clavam than the wild-type culture, but by 96 h the difference was no longer statistically significant (data not shown). Despite considerable variation in clavam content between replicate cultures of the same strains, these temporal differences in clavam levels between the mutants and the wild-type culture were observed consistently, and the higher clavam levels were always seen in the bli mutants. Furthermore this variation in clavam production was seen even though DNA measurements indicated very similar extents of growth in the replicate cultures. This variability in replicate cultures despite rigorous attempts to produce cultures as near to identical as possible suggests that clavam production is highly sensitive to growth conditions and growth stages.
When the level of hydroxymethyl clavam produced by the bli\claR double mutant and the claR mutant was compared, no difference was detected at 72 h or 96 h despite an initial lag in production shown by the bli\claR double mutant at 48 h (data not shown).
Comparisons of clavulanic acid production by the wildtype and bli mutant showed that higher levels of clavulanic acid were seen in the bli mutant compared to wild-type cultures at 48 h when clavulanic acid was just beginning to be detected in cultures. Similar amounts of clavulanic acid were detected at 72 or 96 h for both bli and wild-type cultures (data not shown).
Examination of the DNA sequence flanking the bli gene
The gene encoding the BLIP-like protein, blp, is located in the cephamycin biosynthetic gene cluster (PerezLlarena et al., 1997a) in close proximity to ccaR, a pathway-specific regulator of cephamycin C and clavulanic acid production. Since the bli mutation had effects, albeit transient, on clavam production, it seemed possible that BLIP could be involved in the regulation of clavam production. Therefore, it was of interest to determine whether a regulatory gene might be located near bli, just as ccaR is located near to blp.
The regions upstream and downstream of bli were sequenced using pBIP, the cosmid from which the bli gene was initially cloned (Doran et al., 1990) , as template. The resulting 3876 bp sequence can be found in GenBank, accession number M34538. The blp gene is flanked on the 5h end by the ccaR and orf11 and on the 3h end by the genes encoding early enzymes of cephamycin biosynthesis (Perez-Llarena et al., 1997a) . In contrast, the bli gene is flanked on the 5h end by an ORF, bliup1, located 388 bp upstream and oriented diver- gently to the bli gene. The bliup1 gene is 527 bp in length and encodes a predicted protein of 175 amino acids with a GTG start codon at nt 1009 and a possible Shine-Dalgarno sequence (G AAA GG) 7 bp upstream of the start codon.  analysis of Bliup1 shows some similarity to a hypothetical protein from Streptomyces coelicolor (24 % identical, 39 % similar amino acids) but there is no indication of possible function. The translational stop codon of the bliup1 gene (TGA at nt 484) overlaps the translation start codon (GTG at nt 485) of a second ORF, bliup2. Although the sequence of bliup2 is incomplete,  analysis of the first 161 amino acids of the predicted protein showed similarity to a number of putative DNA binding proteins from S. coelicolor A3(2). On the 3h end, bli is flanked by a pair of overlapping genes which encode proteins showing homology to the ATP-binding domain of an ABC transporter, and a third ORF showing no homology to known proteins. The first of these ORFs, abcA, is located 68 bp downstream from the bli gene and encodes a protein of 150 amino acids. A potential ribosome-binding site (GAA CCA GG) is located 4 bp upstream of the ATG start codon. A glycine-rich Walker A motif which typifies all ATPbinding proteins and is believed to interact with ATP (Mendez & Salas, 1998 ) is evident at amino acids 42-50. The second ORF, abcAh, overlaps the abcA gene. No typical start codon (ATG, GTG, TTG) can be found for the abcAh gene. A possible ribosome-binding site (GGG AAC GG) can be identified 6 bp upstream of an ATT codon in-frame with the abcAh ORF ; however, ATT is an extremely rare start codon (Butler et al., 1987) . Since no likely start codon could be found for the abcAh gene, and to ensure that the unusual arrangement of the abcA\Ah gene was not an artifact that had occurred during the construction and analysis of the blicontaining cosmid clone, the corresponding region was amplified by PCR from the genome of S. clavuligerus and sequenced. The PCR-amplified region of the genome was exactly the same size and had the same sequence as the cloned region (data not shown). Starting from the ATT codon, the predicted AbcAh peptide is 106 amino acids in length and includes the Walker B motif. The Walker B motif extends from amino acids 43 to 48 and encodes a stretch of hydrophobic amino acids including the conserved aspartic acid (D) residue thought to interact with magnesium in this class of proteins. Taken together, the overlapping abcA and abcAh ORFs show all of the motifs known to be conserved in ATP-binding proteins, but they are present on two separate ORFs. The on-line version of this paper (available at http :\\mic.sgmjournals.org) contains a supplementary figure showing the overlap of the abcA and abcAh genes. Alignment of the ORFs with ATP-binding proteins of a S. coelicolor ABC transporter (CAB48895, GenBank) and of a Neisseria meningitidis ABC transporter (AAF41615, GenBank) shows extensive sequence identity and similarity throughout much of the predicted amino acid sequence of both AbcA and AbcAh (Fig. 4) . The AbcA protein shows homology to the N- terminal half of the ATP-binding proteins while the AbcAh protein is homologous to the C-terminal portion of the same ATP-binding proteins. The N-and Cterminal regions of the S. coelicolor and N. meningitidis ATP-binding proteins that show similarity to AbcA and AbcAh are 20 and 22 amino acids apart respectively (Fig.  4) . However, based on sequence alignment, the analogous regions of the S. clavuligerus proteins overlap since the part of the putative AbcA sequence that shows good homology extends at least as far as amino acid 115 whereas the region of good homology in AbcAh begins at what is equivalent to amino acid 103 relative to the AbcA start codon (amino acid 14 of AbcAh).
The third ORF downstream from bli is incomplete, extending for 1220 bp from a start codon (GTG) that overlaps the translational stop codon of the abcAh gene to the end of the sequenced region. This partial ORF shows no homology to known proteins although at least six regular stretches of hydrophobic amino acid residues that could represent the membrane-spanning domains (MSDs) of a transmembrane protein can be identified by Kyte-Doolittle hydropathy analysis (Kyte & Doolittle, 1982) .
Expression of BLIP in a ccaR mutant
Since disruption of bli showed transient effects on the production of clavulanic acid and the other clavam compounds, it was of interest to determine whether the expression of bli was under the control of CcaR, the pathway-specific regulator of both clavulanic acid and cephamycin C production. Fig. 5 compares levels of BLIP in the culture supernatants of wild-type S. clavuligerus, the bli single mutant and a ccaR deletion mutant (Alexander & Jensen, 1998) . Culture supernatants were analysed by Western analysis using anti-BLIP antibodies. Although optical densities indicated comparable levels of growth, the amount of BLIP detected in the supernatant of the wild-type cultures was noticeably greater than that detected in the ccaR mutant culture supernatant, at all time points studied. While the effect of ccaR disruption on BLIP production was not absolute, the significant decrease in BLIP production levels seen in the ccaR mutant does suggest that CcaR may regulate expression of BLIP.
The absence of any anti-BLIP-reactive material in the bli mutant suggests that all of the reactive bands observed in the wild-type are related to BLIP and not to crossreacting material. Furthermore, the absence of any anti-BLIP-reactive material in the bli mutant also indicates that BLP, if it is produced under these conditions, must be sufficiently different from BLIP that it does not crossreact with BLIP-specific antibodies.
DISCUSSION
The production of β-lactamase-inhibitory proteins has been characterized in two Streptomyces species, S. clavuligerus (Doran et al., 1990) and S. exfoliatus (Kim & Lee, 1994) . However little is known of the function of these proteins in the producer organisms. In S. clavuligerus, clavulanic acid is produced in addition to a β-lactamase-inhibitory protein (BLIP), raising the question of why two β-lactamase inhibitors are required. BLIP non-producer mutants were generated in S. clavuligerus to investigate the role of BLIP in growth and β-lactam metabolite production. A double mutant, defective in the production of both BLIP and clavulanic acid, was also constructed to determine the relevance of β-lactamase inhibitors to S. clavuligerus. The isolation of a bli mutant indicates that BLIP is not an essential gene product, while the isolation of a bli\claR mutant also suggests that the production of β-lactamase inhibitors is not essential for the survival of S. clavuligerus.
The bli mutant showed no indication of proteinaceous β-lactamase inhibitors when culture supernatants were assayed for BLIP activity. This result shows that no second β-lactamase-inhibitory protein exists in S. clavuligerus, in contrast to the situation in S. exfoliatus, where two different β-lactamase-inhibitory proteins are produced. Furthermore, since S. clavuligerus contains a gene encoding a BLIP-like protein (BLP ; Perez-Llarena et al., 1997a) , the absence of proteinaceous β-lactamase inhibitors in the bli mutants indicates that BLP has no β-lactamase-inhibitory activity despite its similarity to BLIP. No β-lactamase-inhibitory activity of any type was detected in the culture supernatant of the bli\claR double mutant.
Both the bli mutant and the bli\claR double mutant were analysed for aberrant growth phenotypes and were found to be indistinguishable from the wild-type with respect to cell morphology during growth and differentiation and ability to sporulate. This indicates that BLIP in particular, and β-lactamase inhibitors in general, play no apparent role in the growth and development of S. clavuligerus. This observation is in marked contrast to the bald phenotype seen in mutants of S. exfoliatus defective in the production of BLIP-I.
The resistance of the S. clavuligerus mutants to penicillin G in liquid and surface-grown cultures was also studied. No apparent differences in resistance were seen among the wild-type, claR mutant, bli mutant and bli\claR double mutant strains in either spores or germinated mycelia. Although BLIP is active against the β-lactamase of S. clavuligerus, it does not seem to affect the innate resistance of S. clavuligerus to penicillin G either in surface-grown or in liquid cultures. This result is in agreement with previous findings that the resistance of S. clavuligerus cultures to β-lactam antibiotics is a result of the production of penicillin-binding proteins having low affinity for β-lactams (Ogawara & Horikawa, 1980 ; Paradkar et al., 1998) .
Comparison of cephamycin C production showed no apparent differences among the wild-type and the various mutants, supporting the conclusion that BLIP does not play a role in the production of antibiotic. It also suggests that BLIP does not play a role in the protection of S. clavuligerus against its own antibiotic products.
The disruption of the bli gene had little effect on most aspects of S. clavuligerus production of secondary metabolites with the exception of the production of the clavams. Both the bli mutant and the bli\claR double mutant showed transiently elevated levels of clavam-2-carboxylate production when compared to the wildtype and the claR mutant. A similar pattern was seen for both hydroxymethyl clavam and clavulanic acid. Although the effect of bli disruption on secondary metabolite production was limited to a transient effect on clavulanic acid and the clavams, the observation that bli expression was reduced in a ccaR mutant does suggest some kind of regulatory association between bli and β-lactam metabolite production. ccaR is located within the cephamycin\clavulanic acid gene supercluster, flanked on its downstream side by two genes of unknown function, orf11 and blp (Perez-Llarena et al., 1997a) . Since blp resembles bli and is located near ccaR, it was of interest to determine if a regulatory gene resembling ccaR might also be located near bli. DNA sequence information was obtained for a 1396 bp region upstream of bli. Within that region, one complete ORF, bliup1, and a partial ORF, bliup2, were evident. Database searches indicated that the protein encoded by bliup1 shows no similarity to proteins of known function while the partial bliup2 gene product resembled several DNA-binding proteins from S. coelicolor. Although it remains to be determined whether Bliup2 is a regulatory protein involved in clavam production, it does not belong to the SARP (Streptomyces antibiotic-regulatory protein) family of pathway-specific transcriptional activators, which includes CcaR (Wietzorrek & Bibb, 1997) .
Analysis of 1874 bp of DNA sequence obtained from downstream of bli showed the presence of a pair of ORFs, abcA and abcAh, both having high similarity to ATP-binding proteins of ABC-type transporters. The abcA and abcAh ORFs each contain one of the two Walker motifs which typify ATP-binding proteins of ABC-type transporters. Although all nucleotide-binding proteins identified to date contain these conserved motifs in a single polypeptide, in the current study they were found on separate and overlapping ORFs. In other known Streptomyces ABC transporters, two absolutely conserved K and D residues in Walker A and B motifs respectively range from 116 to 149 amino acids apart (Mendez & Salas, 1998) . The same residues in the ATPbinding proteins in this system are located on separate polypeptides. Although an ATG start codon and a potential ribosome-binding site can be identified for the abcA gene, no typical start codon was found for the abcAh gene. An in-frame ATT codon and potential ribosome-binding site could be seen upstream of the highly conserved region in the abcAh gene ; however, it is unlikely that this is a translational start for the abcAh gene, since there is only one protein known which has an ATT start codon. The translation initiation factor IF(3) protein uses an ATT start codon as a cis element in the autoregulation of its own translation (Butler et al., 1987) . PCR amplification and sequence analysis of the corresponding region from the genome of S. clavuligerus confirmed that the unusual arrangement of the abcA\Ah gene was not an artifact that had occurred during the construction and analysis of the bli-containing cosmid clone. Further evidence against a deletion event is that portions of the amino acid sequence of both AbcA and AbcAh that show similarity to other ATP-binding proteins are encoded by the same 36 bp DNA region. Therefore, it is not clear if abcA and abcAh encode a functional two-part ATP-binding protein of an ABC transporter, or whether they represent a defective gene. However, the existence of another pair of atypical ABC transporter genes has been reported in the gene cluster encoding production of the antibiotic epidermin by Staphylococcus epidermidis. In this organism, the epiT gene encodes a 148 amino acid polypeptide ; with a k1 frame shift a second gene, epiTh, follows. Together the EpiT and EpiTh proteins are similar to one-component ABC transporters and are implicated in epidermin transport. The authors propose that these genes may compose a two-part ABC exporter, or that they may form a single exporter through a shift in reading frame (Fath & Kolter, 1993) .
ABC transporters consist of both ATP-binding domains and membrane-spanning domains (MSDs), either as separate polypeptides or combined in various arrangements. A third incomplete ORF was identified immediately downstream of the abcA\Ah ORFs. This partial ORF shows no similarity to known proteins, yet the presence of six hydrophobic MSDs can be predicted by the hydrophobic analysis method of Kyte & Doolittle (1982) . Possibly this ORF encodes the MSD of the ABC transporter whose ATP-binding domains are encoded by abcA\Ah. Although the presumptive MSD-encoding ORF has not been completely sequenced, the lack of similarity to other MSDs is consistent with the observation that little sequence conservation exists among the MSDs of bacterial ABC transporters (Fath & Kolter, 1993) .
The effect of the bli gene disruption on the time course of production of clavams, and the identification of genes encoding an ABC transporter immediately downstream of the bli gene, together raised the question of whether BLIP and the ABC transporter might be involved in the secretion of clavams into the culture media. It seems unlikely that the ABC transporter is involved in the secretion of BLIP itself because bli encodes a protein with a typical signal peptide which is processed during secretion of the mature protein. Furthermore, the cloned bli gene expresses functional mature BLIP when expressed in E. coli (data not shown). Alternatively, BLIP may be involved together with the ABC transporter in the secretion of some other product. In addition to the ATPbinding protein and MSD, ABC transporters can also contain proteins described as accessory factors. In Gram-negative organisms, accessory factors are believed to aid in export through the inner and outer membrane by spanning the periplasm, connecting these two membranes. It is not clear what role accessory proteins play in Gram-positive organisms ; however, accessory factors linked to ABC transporters of Gram-positive bacteria such as Bacillus subtilis, Streptococcus pneumoniae and Lactococcus lactis have been described (Fath & Kolter, 1993) . Genes encoding accessory factors are invariably found to be linked to the ABC transporter genes (Fath & Kolter, 1993) . Perhaps BLIP functions as an accessory protein for this ABC transporter that in turn plays some role in the excretion of clavam metabolites. However, disruption of bli would then be expected to impede rather than accelerate the production of clavam metabolites.
It remains unclear how the bli mutation results in the observed transient effects on clavam production. However, if the mutation in bli does exert its effects indirectly through the ABC transporter system, it cannot be due to polar effects of the bli mutation on the transcription of the genes, since previous studies have shown that BLIP is produced from a monocistronic transcript (Paradkar et al., 1994) .
